Skip to content

Research at St Andrews

ATP evokes Ca2+ responses and CXCL5 secretion via P2X4 receptor activation in human monocyte-derived macrophages

Research output: Contribution to journalArticlepeer-review


Open Access permissions




Janice A Layhadi, Jeremy Turner, David Crossman, Samuel J Fountain

School/Research organisations


Leukocytes sense extracellular ATP, a danger-associated molecular pattern, released during cellular stress and death, via activation of cell surface P2X and P2Y receptors. Here, we investigate P2 receptor expression in primary human monocyte-derived macrophages and receptors that mediate ATP-evoked intracellular [Ca2+]i signals and cytokine production in response to ATP concentrations that exclude P2X7 receptor activation. Expression of P2X1, P2X4, P2X5, P2X7, P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, and P2Y13 was confirmed by quantitative RT-PCR and immunocytochemistry. ATP elicited intracellular Ca2+ responses in a concentration-dependent fashion (EC50 = 11.4 ± 2.9 μM, n = 3). P2Y11 and P2Y13 activations mediated the amplitude of [Ca2+]i response, whereas P2X4 activation, but not P2X1 or P2X7, determined the duration of Ca2+ response during a sustained phase. ATP mediated gene induction of CXCL5, a proinflammatory chemokine. P2X4 antagonism (PSB-12062 or BX430) inhibited ATP-mediated induction of CXCL5 gene expression and secretion of CXCL5 by primary macrophage. Inhibition of CXCL5 secretion by P2X4 antagonists was lost in the absence of extracellular Ca2+ Reciprocally, positive allosteric modulation of P2X4 (ivermectin) augmented ATP-mediated CXCL5 secretion. P2X7, P2Y11, or P2Y13 receptor did not contribute to CXCL5 secretion. Together, the data reveals a role for P2X4 in determining the duration of ATP-evoked Ca2+ responses and CXCL5 secretion in human primary macrophage.



Original languageEnglish
Pages (from-to)1159-1168
JournalThe Journal of Immunology
Issue number3
Early online date18 Dec 2017
Publication statusPublished - 1 Feb 2018

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial

    Mullen, M., Jin, X. Y., Child, A., Stuart, A. G., Dodd, M., Aragon-Martin, J. A., Gaze, D., Kiotsekoglou, A., Yuan, L., Hu, J., Foley, C., Van Dyck, L., Knight, R., Clayton, T., Swan, L., Thomson, J. D. R., Erdem, G., Crossman, D., Flather, M. & AIMS Investigators, 21 Dec 2019, In: Lancet. 394, 10216, p. 2263-2270

    Research output: Contribution to journalArticlepeer-review

  2. A therapeutic antibody targeting osteoprotegerin attenuates severe experimental pulmonary arterial hypertension

    Arnold, N. D., Pickworth, J. A., West, L. E., Dawson, S., Carvalho, J. A., Casbolt, H., Braithwaite, A. T., Iremonger, J., Renshall, L., Germaschewski, V., McCourt, M., Bland-Ward, P., Kowash, H., Hameed, A. G., Rothman, A. M. K., Frid, M. G., Roger Thompson, A. A., Evans, H. R., Southwood, M., Morrell, N. W. & 7 others, Crossman, D. C., Whyte, M. K. B., Stenmark, K. R., Newman, C. M., Kiely, D. G., Francis, S. E. & Lawrie, A., 15 Nov 2019, In: Nature Communications. 10, 18 p., 5183.

    Research output: Contribution to journalArticlepeer-review

  3. Interleukin-1 beta inhibition with canakinumab and reducing lung cancer-subset analysis of the canakinumab anti-inflammatory thrombosis outcome study trial (CANTOS)

    Crossman, D. & Rothman, A. M. K., 18 Sep 2018, In: Journal of Thoracic Disease. 10, Suppl 26, p. S3084-S3087

    Research output: Contribution to journalEditorialpeer-review

  4. Dietary docosahexaenoic acid reduces oscillatory wall shear stress, atherosclerosis and hypertension, most likely mediated via an IL-1-mediated mechanism

    Alfaida, M., Chamberlain, J., Rothman, A., Crossman, D. C., Villa-Uriol, M-C., Hadoke, P., Wu, J., Schenkel, T., Evans, P. & Francis, S., 3 Jul 2018, In: Journal of the American Heart Association. 7, 13, 19 p., e008757.

    Research output: Contribution to journalArticlepeer-review

  5. Canakinumab for atherosclerotic disease

    MRC-ILA Heart investigators, Rothman, A. M., Morton, A. C. & Crossman, D. C., 11 Jan 2018, In: New England Journal of Medicine. 378, 2, p. 197-8 2 p.

    Research output: Contribution to journalArticlepeer-review

Related by journal

  1. Direct antiviral activity of interferon stimulated genes is responsible for resistance to paramyxoviruses in ISG15-deficient cells

    Holthaus, D., Vasou, A., Bamford, C., Andrejeva, J., Paulus, C., Randall, R. E., McLauchlan, J. & Hughes, D. J., 22 Jun 2020, In: The Journal of Immunology. 11 p., ji1901472.

    Research output: Contribution to journalArticlepeer-review

  2. T cell immunity to the alkyl hydroperoxide reductase of Burkholderia pseudomallei: a correlate of disease outcome in acute melioidosis

    Reynolds, C., Goudet, A., Jenjaroen, K., Sumonwiriya, M., Rinchai, D., Musson, J., Overbeek, S., Makinde, J., Quigley, K., Manji, J., Spink, N., Yos, P., Wuthiekanun, V., Bancroft, G., Robinson, J., Lertmemongkolchai, G., Dunachie, S., Maillere, B., Holden, M., Altmann, D. & 1 others, Boyton, R., 15 May 2015, In: The Journal of Immunology. 194, 10, p. 4814-4824 11 p.

    Research output: Contribution to journalArticlepeer-review

  3. Evolution and Survival of Marine Carnivores Did Not Require a Diversity of Killer Cell Ig-Like Receptors or Ly49 NK Cell Receptors

    Hammond, J. A., Guethlein, L. A., Abi-Rached, L., Moesta, A. K. & Parham, P., 15 Mar 2009, In: The Journal of Immunology. 182, 6, p. 3618-3627 10 p.

    Research output: Contribution to journalArticlepeer-review

  4. Identification of a Novel IL-1 Cytokine Family Member in Teleost Fish

    Wang, T., Bird, S., Koussounadis, A., Holland, J. W., Carrington, A., Zou, J. & Secombes, C. J., 15 Jul 2009, In: The Journal of Immunology. 183, 2, p. 962-974 13 p.

    Research output: Contribution to journalArticlepeer-review

ID: 252030142